- Intellectual Property (99)
- Information Technology (82)
- Company/Commercial (76)
- Litigation / Dispute Resolution (70)
- Insolvency & restructuring (58)
- Banking / Finance (49)
- Pensions (42)
- Employment (39)
- Media/Entertainment/Sport (39)
- Pharma/Biotech (35)
- Real Estate (28)
- Financial services (26)
- Tax (26)
- Regulatory and compliance (22)
- Corporate (20)
- Healthcare (18)
- Telecoms (18)
- Business Tax (12)
- Private Equity (8)
- Competition/EU (7)
- Energy (7)
- Funds (7)
- Environment (6)
- Licensing/Gaming/Betting (5)
- Other (5)
- Insurance/reinsurance (4)
- Transport (Including aviation and shipping) (4)
- Crime (3)
- Personal tax / Trusts (3)
- Construction (2)
- Immigration (2)
- Human Rights (1)
- Planning (1)
- Private Client (1)
- Public Sector/Local Authority (1)
Sort By: Newest first | Oldest first
The VAT pilot programme (initially launched in Shanghai on 1 January 2012) provides for VAT exemption for certain qualified cross-border services that are rendered by a service provider in China to an overseas service recipient.
In this briefing, Taylor Wessing looks at the termination process for senior executives in various countries.
Each EU member state has different mandatory legal requirements protecting players, and these requirements generally apply to the terms that games businesses enter into with them.
The European Commission has announced a proposal for a Directive on trade secrets and confidential business information.
Dr Michael Krämer, senior associate and energy specialist at Taylor Wessing, Dubai, outlines where he sees opportunities for the solar sector in the UAE.
The considerable duration of EPO proceedings will continue to point in favour of refusing a stay of English proceedings in most cases.
This is the second of four articles summarising the general duties and potential liabilities of a director of an English private company (which is not in a group with a PLC).
This is the first of four articles summarising the general duties and potential liabilities of a director of an English private company (which is not in a group with a PLC).
The European Medicines Agency is currently developing a policy on the proactive publication of clinical-trial data.
This is the third of four articles summarising the general duties and potential liabilities of a director of an English private company (which is not in a group with a PLC).
This article provides guidance for companies offering internship programmes when considering whether or not to pay NMW.
Pharmaceutical benefit assessments play an increasingly important role in refunds by the national health services.
Incubators are not often commonly associated with corporates or business enterprises, yet young companies can benefit greatly from a period of ‘incubation’.
In September 2012, the European Commission adopted a proposal for a regulation on in vitro diagnostic medical devices.
This is the fourth of four articles summarising the general duties and potential liabilities of a director of an English private company (which is not in a group with a PLC).
The Advocate General’s opinion in Georgetown University has been released. It fails to recommend whether or not more than one SPC can be granted based on the same patent.
The proprietor owned the trademark CATWALK registered since 1995. In 2010, an application was filed to revoke this word mark on grounds of non-use.
An application for an EU mark ZEBEXIR in classes three and five was opposed by the owner of the earlier mark ZEBINIX for identical goods in classes three and five and services in class 42.
The latest decision concerns a dispute over Zynga’s launch of an online game in January 2012: ‘Scramble with Friends’.
In Asos v Assos, the High Court reviewed the approach to be taken to many issues that arise frequently when considering trademark conflicts.